Utility of lentil lectin affinity of α-fetoprotein in the diagnosis of hepatocellular carcinoma

Journal of Hepatology

Volumn 25, Issue 2, 1996, Pages 166-171

  Wang, Sun Sang ^a   Lu, Rei Hwa ^a   Lee, Fa Yauh ^a   Chao, Yee ^a   Huang, Yi Shin ^a   Chen, Chun Chia ^a   Lee, Shou Dong ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatitis; Hepatocellular carcinoma; Lentil lectin affinity; Fetoprotein

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; HEPATITIS; HUMAN; HUMAN CELL; LECTIN BINDING; LIVER CELL CARCINOMA; MALE; MASS SCREENING; PRIORITY JOURNAL;

EID: 0030220867     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80069-9     Document Type: Article

References (26)

1. Zhou X.D., Tang Z.Y., Yu Y.Q., Yang B.H., Lin Z.Y., Lu J.Z., Ma Z.C., Tang C.L. Long-term survivors after resection of primary liver cancer. Cancer. 63:1989;2201-2206.
2. Iwatsuki S., Starzl T.E., Sheahan D.G., Yokoyama I., Demetris A.J., Todo S., Tzakis A.G., Van Thiel D.H., Carr B., Selby R., Madariaga J. Hepatic resection versus tranplantation for hepatocellular carcinoma. Ann Surg. 214:1991;221-229.
3. Lin D.Y., Liaw Y.F., Lee T.Y., Lai C.M. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma - a randomized controlled trial. Gastroenterology. 94:1988;453-456.
4. Shiina S., Takagawa K., Unuma T., Takanashi R., Yoshiura K., Komatsu Y., Hata Y., Niwa Y., Shiratori Y., Terano A., Sugimoto T. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer. 68:1991;1524-1530.
5. Karvountzis G.G., Redeker A.G. Relationships of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med. 80:1974;156-160.
6. 1-fetoprotein in chronic liver disease. N Engl J Med. 291:1974;506-508.
7. Bloomer J.R., Waldmann T.A., McIntire K.R., Klatskin G. Serum alpha-fetoprotein in patients with massive hepatic necrosis. Gastroenterology. 72:1977;479-482.
8. Alpert E., Feller E.R. α-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis. Gastroenterology. 74:1978;856-858.
9. Liaw Y.F., Yang S.S., Chen T.S., Chu C.M. Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis: a clinicopathological study. J Hepatol. 1:1985;227-233.
10. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H., Kawashima T. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 328:1993;1797-1801.
11. Buamah P.K., Cornell C., Cassels-Smith A.J., Skillen A.W. Differential reactivity of α-fetoprotein with lectins and its usefulness in the diagnosis of various liver disease. Clin Chim Acta. 168:1987;69-73.
12. Aoyagi Y., Suzuki Y., Isemura M., Nomoto M., Sekine C., Igarashi K., Ichida F. The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer. 61:1988;769-774.
13. Taketa K., Endo Y., Sekiya C., Tanikawa K., Koji T., Taga H., Satomura S., Matsuura S., Kawai T., Hirai H. A collaborative study for the evaluation of lectin-reactive α-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 53:1993;5419-5423.
14. Sato Y., Nakata K., Kato Y., Shima M., Ishii N., Koji T., Taketa K., Endo Y., Nagataki S. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med. 28:1993;1802-1806.
15. Taketa K., Sekiya C., Namiki M., Akamatsu K., Ohta Y., Endo Y., Kosaka K. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Gastroenterology. 99:1990;508-518.
16. Shimizu K., Taniichi T., Satomura S., Matsuura S., Taga H., Taketa H. Establishment of assay kits for the determination of microheterogeneities of alpha-fetoprotein using lectin-affinity electrophoresis. Clin Chim Acta. 214:1993;3-12.
17. Ransohoff D.F., Feinstein A.R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 299:1978;926-930.
18. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
19. Chan C.Y., Lee S.D., Wu J.C., Lin H.C., Huang Y.S., Lo G.H., Lee F.Y., Tsai Y.T., Lo K.J. The diagnostic value of the assay of des-γ-carboxy prothrombin in the detection of small hepatocellular carcinoma. J Hepatol. 13:1991;21-24.
20. Grieco A., De Stefano V., Cassano A., Ciabattoni A., Garufi C., Astone A., Leone G., Barone C. Hepatocarcinoma in cirrhosis: is antithrombin III a neoplastic marker. Dig Dis Sci. 36:1991;990-992.
21. Wu J.C., Lee S.D., Hsiao K.J., Wang S.S., Chou P., Tsao D., Tsai Y.T., Lui W.Y., Chiang J.H., Lo K.J. Mass screening of primary hepatocellular carcinoma by alpha-fetoprotein in a rural area of Taiwan - a dried blood spot method. Liver. 8:1988;100-104.
22. Govindarajan S., Fong T.L., Ashcavai M. Concanavalin A affinity of -fetoprotein: its use in differentiating tumors. Am J Clin Pathol. 88:1987;722-724.
23. Wang S.S., Govindarajan S., Lee S.D., Ashcavai M. α-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B. Am J Gastroenterol. 84:1989;46-48.
24. Liaw Y.F., Tai D.I., Chen T.J., Chu C.M., Huang M.J. Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma. Liver. 6:1986;133-137.
25. Liaw Y.F., Tai D.I., Chu C.M., Pao C.C., Chen T.J. Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody-positive patients. Hepatology. 7:1987;20-23.
26. Aoyagi Y., Saitoh A., Suzuki Y., Igarashi K., Oguro M., Yokota T., Mori S., Suda T., Isemura M., Asakura H. Fucosylation index of α-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 17:1993;50-52.